Caley Castelein's Net Worth
$3.12 Million
Who is Caley Castelein?
Caley Castelein has an estimated net worth of $3.12 Million. This is based on reported shares across multiple companies, which include ViewRay, Inc., Aadi Bioscience, Inc., Neos Therapeutics, Inc., and Tourmaline Bio, Inc..
SEC CIK
Caley Castelein's CIK is 0001355758
Past Insider Trading and Trends
2018 was Caley Castelein's most active year for acquiring shares with 8 total transactions. Caley Castelein's most active month to acquire stocks was the month of May. 2023 was Caley Castelein's most active year for disposing of shares, totalling 2 transactions. Caley Castelein's most active month to dispose stocks was the month of June. 2018 saw Caley Castelein paying a total of $5,158,167.78 for 867,296 shares, this is the most they've acquired in one year. In 2023 Caley Castelein cashed out on 799,430 shares for a total of $55,643.31, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ViewRay, Inc. (VRAYQ) Snapshot price: $0.000001
InvestorCaley Castelein owns 99,047 units of Common Stock which is worth $0.10. From 2016 to 2023 Caley Castelein acquired a total of 902,862 shares in ViewRay, Inc. at a cost of $5,493,646.01, Caley also disposed a total of 799,430 shares of ViewRay, Inc. equalling to $55,643.31.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -95.95% | -2.35M |
$0.07 | -$165,380.91 | 99.05K |
Jul 19
| |||
Form 4
| +1.88% | 16.59K |
$4.40 | $72,996.00 | 898.48K |
Jan 3
| |||
Form 4
| +6.59% | 54.51K |
—
|
—
| 881.89K |
Jun 13
| |||
Form 4
| +1,083.46% | 1.42M |
$2.54 | $3,601,119.00 | 1.55M |
May 10 - May 11
| |||
Form 4
| +1.53% | 12.52K |
$5.83 | $72,997.43 | 828.38K |
Jan 3
| |||
Form 4
| +2.61% | 20.76K |
$5.82 | $5,831.64 | 815.86K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +1.42% | 11.1K |
$5.82 | $64,628.02 | 795.1K |
Dec 31 - Jan 4
| |||
Form 4
| +7.21% | 52.75K |
—
|
—
| 783.99K |
Jun 15
| |||
Form 4
| +3.96% | 28K |
$4.06 | $61,996.90 | 734.63K |
Jan 2
| |||
Form 4
| +4.24% | 28.73K |
$6.16 | $61,994.24 | 706.63K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
| +306.00% | 510.93K |
$9.98 | $5,099,071.42 | 677.9K |
Aug 17
| |||
Form 4
| +1.91% | 3.13K |
$8.18 | $25,636.12 | 166.97K |
Aug 2
| |||
Form 4
| +2.50% | 4K |
$7.12 | $28,494.24 | 163.84K |
Jul 2
| |||
Form 4
| +5.34% | 8.1K |
—
|
—
| 159.83K |
Nov 15
| |||
Form 4
| +86.07% | 130.6K |
$6.44 | $841,064.00 | 282.33K |
Oct 25
| |||
Form 4
| +601.64% | 130.1K |
—
|
—
| 151.73K |
May 18
| |||
Form 4
|
∞
| 21.63K |
—
|
—
| 21.63K |
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aadi Bioscience, Inc. (AADI) Snapshot price: $1.82
InvestorCaley Castelein owns 295,414 units of Common Stock which is worth $537,653.48. From 2017 to 2024 Caley Castelein acquired a total of 284,494 shares in Aadi Bioscience, Inc. at a cost of $23,747.65.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +92.31% | 240K |
$12.50 | $3,000,000.00 | 500K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 260K |
$13.08 | $3,399,993.85 | 260K |
Aug 26 - Aug 27
| |||
Form 4
| +2.72% | 7.81K |
$1.52 | $11,872.72 | 295.41K |
Jun 30
| |||
Form 4
| +2.75% | 7.7K |
$1.54 | $11,874.93 | 287.6K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| -82.66% | -1.33M |
—
|
—
| 279.91K |
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +33.02% | 400K |
$5.00 | $2,000,000.00 | 1.61M |
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neos Therapeutics, Inc. No price found
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.22M |
—
|
—
| 1.22M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tourmaline Bio, Inc. (TRML) Snapshot price: $16.11
InvestorCaley Castelein owns 516,519 units of Common Stock which is worth $8,321,121.09. In the year 2023 Caley Castelein acquired a total of 516,519 shares in Tourmaline Bio, Inc. at a cost of $280,584.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +4.03% | 20K |
$14.03 | $280,584.00 | 516.52K |
Oct 25 - Oct 27
| |||
Form 4
|
∞
| 954.56K |
—
|
—
| 954.56K |
Oct 19 - Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||